| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.39e-07 | 37 | 97 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.85e-06 | 127 | 97 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 1.20e-05 | 158 | 97 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 6.58e-05 | 206 | 97 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 KIF21A CHD9 CHD1 CHD7 SRCAP FANCM BPTF DDX18 ERCC6L2 MORC3 | 1.93e-04 | 614 | 97 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.07e-04 | 60 | 97 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 2.31e-04 | 5 | 97 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 2.31e-04 | 5 | 97 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.91e-04 | 262 | 97 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.96e-04 | 441 | 97 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | histone binding | 3.11e-04 | 265 | 97 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 5.49e-04 | 137 | 97 | 5 | GO:0019783 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 5.67e-04 | 78 | 97 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | methylated histone binding | 8.19e-04 | 86 | 97 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 8.19e-04 | 86 | 97 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 8.93e-04 | 88 | 97 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 8.95e-04 | 39 | 97 | 3 | GO:0008187 | |
| GeneOntologyMolecularFunction | G-quadruplex RNA binding | 1.02e-03 | 10 | 97 | 2 | GO:0002151 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.49e-03 | 12 | 97 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.55e-03 | 102 | 97 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.66e-03 | 104 | 97 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.95e-03 | 51 | 97 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.96e-03 | 363 | 97 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 2.11e-03 | 111 | 97 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.43e-03 | 55 | 97 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.46e-03 | 192 | 97 | 5 | GO:0008234 | |
| GeneOntologyMolecularFunction | K63-linked deubiquitinase activity | 2.68e-03 | 16 | 97 | 2 | GO:0061578 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 4.14e-03 | 645 | 97 | 9 | GO:0140640 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 4.62e-03 | 21 | 97 | 2 | GO:1990380 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.62e-03 | 21 | 97 | 2 | GO:0042975 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.64e-05 | 269 | 97 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.75e-05 | 287 | 97 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 7.86e-05 | 49 | 97 | 4 | GO:0099523 | |
| GeneOntologyCellularComponent | cytosolic region | 3.16e-04 | 70 | 97 | 4 | GO:0099522 | |
| Domain | SNF2_N | 6.14e-07 | 32 | 97 | 5 | IPR000330 | |
| Domain | SNF2_N | 6.14e-07 | 32 | 97 | 5 | PF00176 | |
| Domain | Helicase_C | 1.40e-06 | 107 | 97 | 7 | PF00271 | |
| Domain | HELICc | 1.40e-06 | 107 | 97 | 7 | SM00490 | |
| Domain | Helicase_C | 1.49e-06 | 108 | 97 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.58e-06 | 109 | 97 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.58e-06 | 109 | 97 | 7 | PS51192 | |
| Domain | DEXDc | 1.58e-06 | 109 | 97 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.68e-06 | 110 | 97 | 7 | IPR014001 | |
| Domain | Bromodomain_CS | 9.36e-06 | 26 | 97 | 4 | IPR018359 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.16e-05 | 35 | 97 | 4 | IPR002464 | |
| Domain | BROMODOMAIN_1 | 3.96e-05 | 37 | 97 | 4 | PS00633 | |
| Domain | DEAH_ATP_HELICASE | 4.41e-05 | 38 | 97 | 4 | PS00690 | |
| Domain | Bromodomain | 4.41e-05 | 38 | 97 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.97e-05 | 41 | 97 | 4 | PS50014 | |
| Domain | BROMO | 6.58e-05 | 42 | 97 | 4 | SM00297 | |
| Domain | Bromodomain | 6.58e-05 | 42 | 97 | 4 | IPR001487 | |
| Domain | - | 6.58e-05 | 42 | 97 | 4 | 1.20.920.10 | |
| Domain | Ago_hook | 7.98e-05 | 3 | 97 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 7.98e-05 | 3 | 97 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 7.98e-05 | 3 | 97 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 7.98e-05 | 3 | 97 | 2 | PF16608 | |
| Domain | CTNNB1-bd_N | 1.59e-04 | 4 | 97 | 2 | IPR013558 | |
| Domain | CTNNB1_binding | 1.59e-04 | 4 | 97 | 2 | PF08347 | |
| Domain | TCF/LEF | 1.59e-04 | 4 | 97 | 2 | IPR024940 | |
| Domain | Chromo_domain | 2.54e-04 | 24 | 97 | 3 | IPR023780 | |
| Domain | DUF4704 | 2.64e-04 | 5 | 97 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.64e-04 | 5 | 97 | 2 | PF15787 | |
| Domain | Chromo | 3.24e-04 | 26 | 97 | 3 | PF00385 | |
| Domain | BRK | 3.95e-04 | 6 | 97 | 2 | SM00592 | |
| Domain | PH_BEACH | 3.95e-04 | 6 | 97 | 2 | PF14844 | |
| Domain | BRK_domain | 3.95e-04 | 6 | 97 | 2 | IPR006576 | |
| Domain | BRK | 3.95e-04 | 6 | 97 | 2 | PF07533 | |
| Domain | CHROMO_1 | 4.05e-04 | 28 | 97 | 3 | PS00598 | |
| Domain | CHROMO_2 | 4.05e-04 | 28 | 97 | 3 | PS50013 | |
| Domain | Peptidase_C48 | 5.51e-04 | 7 | 97 | 2 | PF02902 | |
| Domain | ULP_PROTEASE | 5.51e-04 | 7 | 97 | 2 | PS50600 | |
| Domain | Peptidase_C48_C | 5.51e-04 | 7 | 97 | 2 | IPR003653 | |
| Domain | Chromodomain-like | 6.04e-04 | 32 | 97 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 6.62e-04 | 33 | 97 | 3 | IPR000953 | |
| Domain | CHROMO | 6.62e-04 | 33 | 97 | 3 | SM00298 | |
| Domain | PH-BEACH_dom | 7.32e-04 | 8 | 97 | 2 | IPR023362 | |
| Domain | - | 7.32e-04 | 8 | 97 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 7.32e-04 | 8 | 97 | 2 | PS51783 | |
| Domain | BEACH_dom | 9.39e-04 | 9 | 97 | 2 | IPR000409 | |
| Domain | BEACH | 9.39e-04 | 9 | 97 | 2 | PS50197 | |
| Domain | Beach | 9.39e-04 | 9 | 97 | 2 | PF02138 | |
| Domain | - | 9.39e-04 | 9 | 97 | 2 | 1.10.1540.10 | |
| Domain | Beach | 9.39e-04 | 9 | 97 | 2 | SM01026 | |
| Domain | MIR | 1.17e-03 | 10 | 97 | 2 | PS50919 | |
| Domain | MIR | 1.17e-03 | 10 | 97 | 2 | PF02815 | |
| Domain | MIR | 1.17e-03 | 10 | 97 | 2 | SM00472 | |
| Domain | MIR_motif | 1.17e-03 | 10 | 97 | 2 | IPR016093 | |
| Domain | Kinase-like_dom | 2.03e-03 | 542 | 97 | 9 | IPR011009 | |
| Domain | S_TKc | 2.67e-03 | 359 | 97 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.80e-03 | 362 | 97 | 7 | PS00108 | |
| Domain | Pkinase | 3.71e-03 | 381 | 97 | 7 | PF00069 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.56e-05 | 62 | 72 | 5 | M27321 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.58e-05 | 34 | 72 | 4 | M46422 | |
| Pubmed | HSPD1 FLG TCF7L2 USP9X TNRC6B CHD7 SRCAP MDM2 CREBBP BPTF DST GTF3C1 DDX18 SYNE2 TNRC6A SMN1 SCAF11 ATF1 ZHX1 PPP6R3 SENP5 | 3.37e-10 | 1429 | 97 | 21 | 35140242 | |
| Pubmed | CDK16 JCAD CALD1 USP9X SAMD4B ANKRD26 TNRC6B BIRC6 DST NYNRIN TNRC6A MPHOSPH9 PPP6R3 | 3.74e-10 | 446 | 97 | 13 | 24255178 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | CCPG1 TNRC6B CHD7 SRCAP MDM2 BIRC6 ITPR1 BPTF DST CDK5RAP2 USP33 SENP7 | 4.49e-10 | 363 | 97 | 12 | 14691545 |
| Pubmed | DCAF6 FMR1 TNRC6B CHD9 DGKE SRCAP MDM2 CREBBP DNTTIP2 BPTF BRDT BRPF1 DDX18 SCN5A TNRC6A TCF7L1 RSBN1L SENP7 | 1.75e-09 | 1116 | 97 | 18 | 31753913 | |
| Pubmed | FMR1 USP9X SRPK1 CHD1 CHD7 BIRC6 DNTTIP2 BPTF DST GTF3C1 DDX18 SYNE2 SCAF11 PPP6R3 | 3.93e-09 | 653 | 97 | 14 | 22586326 | |
| Pubmed | DCAF6 FMR1 ANKRD26 LAMA2 ZNF407 MDM2 BIRC6 DNTTIP2 MAP3K5 DST SYNE2 CDK5RAP2 | 1.51e-08 | 497 | 97 | 12 | 23414517 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TCF7L2 CHD9 CHD1 CHD7 SRCAP DNTTIP2 BPTF GTF3C1 BRPF1 SCAF11 MORC3 ZHX1 SENP7 | 1.53e-08 | 608 | 97 | 13 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAF6 TCF7L2 CALD1 PPFIA2 SAMD4B TOM1 TNRC6B PELI2 WASHC3 CHD9 CREBBP CEP43 BPTF GTF3C1 SCAF11 PNPLA7 LRBA RBFOX2 TMEM63A | 2.58e-08 | 1489 | 97 | 19 | 28611215 |
| Pubmed | HSPD1 USP9X SAMD4B SRPK1 DST GTF3C1 DDX18 TNRC6A SDF2L1 RSBN1L RBFOX2 PPP6R3 | 4.31e-08 | 547 | 97 | 12 | 37267103 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CDK16 USP9X ANKRD26 SRPK1 FANCM CREBBP CEP43 GTF3C1 DDX18 SMN1 SCAF11 EIF2AK1 PPP6R3 | 4.75e-08 | 670 | 97 | 13 | 22990118 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 8.63e-08 | 197 | 97 | 8 | 20811636 | |
| Pubmed | HSPD1 CCPG1 GRAMD1A ECD ANKRD26 SRPK1 DGKE CHD1 ZFC3H1 DNTTIP2 ITPR1 DDX18 SYNE2 SDF2L1 CDK5RAP2 EDRF1 USP33 PPP6R3 | 1.39e-07 | 1487 | 97 | 18 | 33957083 | |
| Pubmed | CDK16 FMR1 CALD1 USP9X TOM1 SRPK1 MDM2 DST IGKC SCAF11 PPP6R3 SENP5 | 2.11e-07 | 634 | 97 | 12 | 34591612 | |
| Pubmed | ECD ANKRD26 TNRC6B MED13L SRCAP CREBBP CEP43 DST MPHOSPH9 MORC3 LRBA EDRF1 | 2.54e-07 | 645 | 97 | 12 | 25281560 | |
| Pubmed | CALD1 USP9X TNRC6B SRCAP CREBBP BPTF GTF3C1 LRBA RSBN1L LRRFIP1 PPP6R3 | 4.01e-07 | 549 | 97 | 11 | 38280479 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | FMR1 USP9X ZFC3H1 SRCAP DNTTIP2 ITPR1 GTF3C1 DDX18 SMN1 PPP6R3 | 4.48e-07 | 440 | 97 | 10 | 34244565 |
| Pubmed | JCAD DCAF6 USP9X KIF21A CHD9 ZFC3H1 MED13L CREBBP DST DDX18 MORC3 LRBA EIF2AK1 RSBN1L USP33 LRRFIP1 | 5.21e-07 | 1285 | 97 | 16 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HSPD1 TCF7L2 FMR1 CEBPG CHD7 ZFC3H1 SRCAP FANCM DNTTIP2 BPTF DST GTF3C1 DDX18 SCAF11 ATF1 RBFOX2 | 5.72e-07 | 1294 | 97 | 16 | 30804502 |
| Pubmed | SAMD4B TOM1 TNRC6B SRPK1 CHD1 CHD7 ZFC3H1 DST GZF1 TNRC6A SMN1 SCAF11 ATF1 ZHX1 RSBN1L EDRF1 PPP6R3 | 7.88e-07 | 1497 | 97 | 17 | 31527615 | |
| Pubmed | 7.98e-07 | 469 | 97 | 10 | 27634302 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | HSPD1 RBMS2 TOM1 ANKRD26 SRPK1 MED13L GTF3C1 DDX18 TNRC6A ATXN3 MAP3K13 RBFOX2 | 9.62e-07 | 732 | 97 | 12 | 34732716 |
| Pubmed | HSPD1 AFF2 ANKRD26 TNRC6B NDRG3 BIRC6 DST DDX18 TNRC6A CDK5RAP2 MPHOSPH9 LRBA | 1.79e-06 | 777 | 97 | 12 | 35844135 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 USP9X KIF21A ECD TNRC6B SRPK1 CHD1 BIRC6 DNTTIP2 DDX18 SYNE2 IGKC SDF2L1 SCAF11 LRRFIP1 PPP6R3 | 1.83e-06 | 1415 | 97 | 16 | 28515276 |
| Pubmed | HSPD1 TCF7L2 CALD1 GRAMD1A ECD TOM1 SRPK1 DGKE ITPR1 DST GTF3C1 SYNE2 IGKC SDF2L1 LRRFIP1 PPP6R3 | 2.30e-06 | 1440 | 97 | 16 | 30833792 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.35e-06 | 411 | 97 | 9 | 35182466 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TNRC6B ZNF407 CHD7 MED13L ITPR1 BPTF GZF1 TNRC6A SCAF11 MPHOSPH9 | 2.64e-06 | 536 | 97 | 10 | 15840001 |
| Pubmed | TNRC6B ZNF407 CHD7 MED13L ITPR1 BPTF GZF1 TNRC6A SCAF11 MPHOSPH9 | 2.72e-06 | 538 | 97 | 10 | 10512203 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.40e-06 | 430 | 97 | 9 | 35044719 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HSPD1 JCAD CALD1 ECD ANKRD26 TNRC6B BRPF1 TNRC6A MPHOSPH9 MORC3 RBFOX2 PPP6R3 | 4.64e-06 | 853 | 97 | 12 | 28718761 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 6.06e-06 | 462 | 97 | 9 | 31138677 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 29791863 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20730097 | ||
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 7.70e-06 | 2 | 97 | 2 | 1741298 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21254876 | ||
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 7.70e-06 | 2 | 97 | 2 | 22265015 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30026326 | ||
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 7.70e-06 | 2 | 97 | 2 | 9916915 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30689267 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11119302 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34111553 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20005844 | ||
| Pubmed | Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1. | 7.70e-06 | 2 | 97 | 2 | 17196195 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 8.54e-06 | 170 | 97 | 6 | 23314748 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CALD1 STK26 SRPK1 CHD1 CREBBP DNTTIP2 DST GTF3C1 CDK5RAP2 MAP3K13 RBFOX2 PPP6R3 | 8.89e-06 | 910 | 97 | 12 | 36736316 |
| Pubmed | GRAMD1A ANKRD26 ZNF407 ZFC3H1 FANCM BIRC6 MORC3 EIF2AK1 TMEM63A | 1.02e-05 | 493 | 97 | 9 | 15368895 | |
| Pubmed | HSPD1 FLG CALD1 TTC16 PPFIA2 KIF21A ECD ANKRD26 ZFC3H1 SRCAP DNTTIP2 BPTF DST GTF3C1 SYNE2 | 1.08e-05 | 1442 | 97 | 15 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 CALD1 ECD ANKRD26 TNRC6B CHD1 SRCAP DNTTIP2 DST LRBA RSBN1L PPP6R3 | 1.15e-05 | 934 | 97 | 12 | 33916271 |
| Pubmed | 1.21e-05 | 504 | 97 | 9 | 34432599 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HSPD1 CALD1 RBMS2 CHD1 CHD7 FANCM DNTTIP2 BPTF DDX18 SCAF11 ATF1 RSBN1L | 1.42e-05 | 954 | 97 | 12 | 36373674 |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.66e-05 | 18 | 97 | 3 | 25363768 | |
| Pubmed | 1.66e-05 | 18 | 97 | 3 | 33323119 | ||
| Pubmed | HSPD1 JCAD FMR1 KIAA0513 USP9X PPFIA2 GRAMD1A TNRC6B NDRG3 BIRC6 ITPR1 TNRC6A LRRFIP1 | 1.70e-05 | 1139 | 97 | 13 | 36417873 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.89e-05 | 533 | 97 | 9 | 30554943 | |
| Pubmed | 1.97e-05 | 19 | 97 | 3 | 18329113 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17607356 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25659031 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 2.31e-05 | 3 | 97 | 2 | 24463605 | |
| Pubmed | Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease. | 2.31e-05 | 3 | 97 | 2 | 31263572 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18093976 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 34525377 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 32403323 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31670606 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 10196247 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31425296 | ||
| Pubmed | Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. | 2.31e-05 | 3 | 97 | 2 | 20962272 | |
| Pubmed | Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity. | 2.31e-05 | 3 | 97 | 2 | 29016848 | |
| Pubmed | Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. | 2.31e-05 | 3 | 97 | 2 | 19357310 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21496457 | ||
| Pubmed | Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation. | 2.31e-05 | 3 | 97 | 2 | 17885668 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20532534 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 10722738 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20413592 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 2.31e-05 | 3 | 97 | 2 | 34108231 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 10347196 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 34303799 | ||
| Pubmed | Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome. | 2.31e-05 | 3 | 97 | 2 | 29950602 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16880270 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31419437 | ||
| Pubmed | CCPG1 FMR1 SRPK1 CHD1 ZFC3H1 DNTTIP2 GTF3C1 BRPF1 DDX18 SMN1 SCAF11 | 2.48e-05 | 847 | 97 | 11 | 35850772 | |
| Pubmed | 2.75e-05 | 209 | 97 | 6 | 36779422 | ||
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 2.87e-05 | 313 | 97 | 7 | 16196087 | |
| Pubmed | TCF7L2 IKZF1 NDRG3 BIRC6 CREBBP RNF115 GTF3C1 MTF1 BRPF1 TCF7L1 | 2.97e-05 | 709 | 97 | 10 | 22988430 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FMR1 CALD1 RBMS2 ANKRD26 TNRC6B ZFC3H1 BRPF1 DDX18 TNRC6A LRRFIP1 | 3.55e-05 | 724 | 97 | 10 | 36232890 |
| Pubmed | 3.58e-05 | 23 | 97 | 3 | 26002199 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 3.95e-05 | 223 | 97 | 6 | 33187986 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.05e-05 | 588 | 97 | 9 | 38580884 | |
| Pubmed | 4.09e-05 | 453 | 97 | 8 | 29656893 | ||
| Pubmed | 4.15e-05 | 225 | 97 | 6 | 12168954 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.18e-05 | 332 | 97 | 7 | 32786267 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 11581372 | ||
| Pubmed | Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. | 4.60e-05 | 4 | 97 | 2 | 12297501 | |
| Pubmed | p300/MDM2 complexes participate in MDM2-mediated p53 degradation. | 4.60e-05 | 4 | 97 | 2 | 9809062 | |
| Pubmed | MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. | 4.60e-05 | 4 | 97 | 2 | 12426395 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 4.60e-05 | 4 | 97 | 2 | 21063388 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 33587034 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 22349818 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 18458062 | ||
| Pubmed | Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer. | 4.60e-05 | 4 | 97 | 2 | 26802432 | |
| Pubmed | In vivo association of CReMM/CHD9 with promoters in osteogenic cells. | 4.60e-05 | 4 | 97 | 2 | 16419031 | |
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 4.60e-05 | 4 | 97 | 2 | 17065530 | |
| Interaction | H3-3A interactions | TCF7L2 CHD9 CHD1 CHD7 SRCAP CREBBP DNTTIP2 BPTF GTF3C1 BRPF1 SCAF11 MORC3 ZHX1 LRRFIP1 SENP7 PPP6R3 | 5.40e-07 | 749 | 97 | 16 | int:H3-3A |
| Interaction | SYNE3 interactions | JCAD CCPG1 GRAMD1A SAMD4B ANKRD26 TNRC6B CEP43 DST SYNE2 TNRC6A CDK5RAP2 MPHOSPH9 | 1.48e-06 | 444 | 97 | 12 | int:SYNE3 |
| Interaction | SUZ12 interactions | HSPD1 FMR1 CHD1 CHD7 MDM2 BIRC6 BPTF GTF3C1 DDX18 TNRC6A SDF2L1 CDK5RAP2 SCAF11 MORC3 | 2.44e-06 | 644 | 97 | 14 | int:SUZ12 |
| Interaction | SIRT7 interactions | FMR1 USP9X SRPK1 CHD1 CHD7 MDM2 BIRC6 DNTTIP2 BPTF DST GTF3C1 DDX18 SYNE2 SCAF11 PPP6R3 | 2.60e-06 | 744 | 97 | 15 | int:SIRT7 |
| Interaction | HDAC1 interactions | HSPD1 TCF7L2 TNRC6B IKZF1 CHD1 MDM2 BIRC6 CREBBP BPTF DST SYNE2 TNRC6A CDK5RAP2 SMN1 LRBA ZHX1 LRRFIP1 PPP6R3 | 4.95e-06 | 1108 | 97 | 18 | int:HDAC1 |
| Interaction | SRSF6 interactions | HSPD1 USP9X KIF21A SRPK1 ZFC3H1 BPTF GZF1 DDX18 TNRC6A SCAF11 RSBN1L PPP6R3 | 5.34e-06 | 503 | 97 | 12 | int:SRSF6 |
| Interaction | TULP3 interactions | 6.54e-06 | 346 | 97 | 10 | int:TULP3 | |
| Interaction | LATS1 interactions | JCAD USP9X ANKRD26 TNRC6B MDM2 CREBBP MTF1 TNRC6A CDK5RAP2 MPHOSPH9 PPP6R3 | 8.74e-06 | 440 | 97 | 11 | int:LATS1 |
| Interaction | MED4 interactions | ECD ANKRD26 TNRC6B MED13L CEP43 DST TNRC6A MPHOSPH9 LRBA EDRF1 LRRFIP1 | 1.08e-05 | 450 | 97 | 11 | int:MED4 |
| Interaction | CSNK2A1 interactions | HSPD1 CDK16 FLG TCF7L2 FMR1 CALD1 GRAMD1A ECD ZFC3H1 MDM2 BIRC6 CREBBP DST ATF1 MAP3K13 ZHX1 | 1.24e-05 | 956 | 97 | 16 | int:CSNK2A1 |
| Interaction | PARP1 interactions | TCF7L2 CALD1 ECD IKZF1 CHD1 CHD7 SRCAP MDM2 CREBBP DNTTIP2 BPTF GTF3C1 MTF1 DDX18 ATXN3 CDK5RAP2 SCAF11 MORC3 RSBN1L | 1.40e-05 | 1316 | 97 | 19 | int:PARP1 |
| Interaction | DCAF4 interactions | HSPD1 RBMS2 KIF21A SAMD4B TNRC6B CHD1 NYNRIN DDX18 TNRC6A RBFOX2 | 1.41e-05 | 378 | 97 | 10 | int:DCAF4 |
| Interaction | GSK3A interactions | DCAF6 FMR1 TTC16 KIF21A ECD TNRC6B SRPK1 CEP43 DST TNRC6A PPP6R3 | 1.43e-05 | 464 | 97 | 11 | int:GSK3A |
| Interaction | ANAPC2 interactions | 1.74e-05 | 234 | 97 | 8 | int:ANAPC2 | |
| Interaction | POLR1G interactions | CHD9 CHD1 CHD7 ZFC3H1 SRCAP DNTTIP2 BPTF GTF3C1 BRPF1 DDX18 RSBN1L | 2.33e-05 | 489 | 97 | 11 | int:POLR1G |
| Interaction | FBXL6 interactions | HSPD1 USP9X SAMD4B SRPK1 DST GTF3C1 DDX18 TNRC6A SDF2L1 RSBN1L RBFOX2 PPP6R3 | 2.33e-05 | 583 | 97 | 12 | int:FBXL6 |
| Interaction | BRCA1 interactions | HSPD1 CDK16 USP9X ANKRD26 TNRC6B CHD9 FANCM CREBBP CEP43 ITPR1 BPTF DST TNRC6A ATF1 MORC3 ZHX1 LRRFIP1 PPP6R3 | 2.52e-05 | 1249 | 97 | 18 | int:BRCA1 |
| Interaction | CEP63 interactions | 2.54e-05 | 179 | 97 | 7 | int:CEP63 | |
| Interaction | ALG13 interactions | 2.93e-05 | 183 | 97 | 7 | int:ALG13 | |
| Interaction | AFDN interactions | 3.29e-05 | 333 | 97 | 9 | int:AFDN | |
| Interaction | GATA3 interactions | 3.36e-05 | 187 | 97 | 7 | int:GATA3 | |
| Interaction | VARS1 interactions | 3.70e-05 | 260 | 97 | 8 | int:VARS1 | |
| Interaction | STIL interactions | 3.72e-05 | 190 | 97 | 7 | int:STIL | |
| Interaction | FAM120C interactions | 3.85e-05 | 191 | 97 | 7 | int:FAM120C | |
| Interaction | EGLN3 interactions | HSPD1 JCAD USP9X SAMD4B ECD TOM1 CHD1 MDM2 BIRC6 CREBBP MAP3K5 GTF3C1 SDF2L1 CDK5RAP2 SMN1 MPHOSPH9 RBFOX2 PPP6R3 | 4.09e-05 | 1296 | 97 | 18 | int:EGLN3 |
| Interaction | SOX2 interactions | HSPD1 TCF7L2 USP9X RBMS2 SAMD4B TOM1 ANKRD26 CHD9 SRPK1 CHD7 MED13L BPTF GTF3C1 DDX18 TNRC6A ATXN3 ATF1 MAP3K13 RBFOX2 | 4.10e-05 | 1422 | 97 | 19 | int:SOX2 |
| Interaction | TRIM52 interactions | 4.46e-05 | 133 | 97 | 6 | int:TRIM52 | |
| Interaction | NUP43 interactions | HSPD1 TNRC6B CHD9 CHD1 ZFC3H1 SRCAP DNTTIP2 BPTF DST DDX18 SYNE2 ZHX1 | 4.59e-05 | 625 | 97 | 12 | int:NUP43 |
| Interaction | SIRT6 interactions | FMR1 USP9X ZFC3H1 SRCAP MDM2 CREBBP DNTTIP2 ITPR1 GTF3C1 DDX18 SMN1 PPP6R3 | 4.80e-05 | 628 | 97 | 12 | int:SIRT6 |
| Interaction | CEP135 interactions | 5.09e-05 | 272 | 97 | 8 | int:CEP135 | |
| Interaction | YWHAZ interactions | CDK16 JCAD PPFIA2 SAMD4B ANKRD26 MDM2 RNF115 MAP3K5 ITPR1 DST NBEAL2 SYNE2 IGKC CDK5RAP2 SCAF11 MPHOSPH9 MORC3 SENP7 | 5.15e-05 | 1319 | 97 | 18 | int:YWHAZ |
| Interaction | NR3C1 interactions | HSPD1 JCAD DCAF6 FMR1 USP9X ECD CHD9 CHD7 MDM2 CREBBP CEP43 SYNE2 SDF2L1 CDK5RAP2 RBFOX2 | 6.21e-05 | 974 | 97 | 15 | int:NR3C1 |
| Interaction | CBX3 interactions | HSPD1 TCF7L2 FMR1 CHD9 SRPK1 IKZF1 CHD1 CHD7 DNTTIP2 GTF3C1 RSBN1L SENP7 | 6.30e-05 | 646 | 97 | 12 | int:CBX3 |
| Interaction | N4BP2 interactions | 7.02e-05 | 89 | 97 | 5 | int:N4BP2 | |
| Interaction | ZBTB38 interactions | 7.22e-05 | 145 | 97 | 6 | int:ZBTB38 | |
| Interaction | YWHAG interactions | HSPD1 CDK16 JCAD SAMD4B ANKRD26 SRPK1 RNF115 DNTTIP2 MAP3K5 DST SYNE2 SCAF11 MPHOSPH9 MORC3 LRBA EDRF1 PPP6R3 | 8.78e-05 | 1248 | 97 | 17 | int:YWHAG |
| Interaction | MIB1 interactions | 8.97e-05 | 295 | 97 | 8 | int:MIB1 | |
| Interaction | RBBP4 interactions | TCF7L2 IKZF1 CHD7 CREBBP BPTF ATXN3 CDK5RAP2 SMN1 ZHX1 LRRFIP1 SENP7 | 9.72e-05 | 573 | 97 | 11 | int:RBBP4 |
| Interaction | MKRN2 interactions | 1.00e-04 | 385 | 97 | 9 | int:MKRN2 | |
| Interaction | EIF4ENIF1 interactions | 1.01e-04 | 300 | 97 | 8 | int:EIF4ENIF1 | |
| Interaction | ARRB1 interactions | 1.10e-04 | 304 | 97 | 8 | int:ARRB1 | |
| Interaction | GLI3 interactions | 1.11e-04 | 98 | 97 | 5 | int:GLI3 | |
| Interaction | SASS6 interactions | 1.20e-04 | 159 | 97 | 6 | int:SASS6 | |
| Interaction | SUMO2 interactions | HSPD1 USP9X SRCAP BPTF DST GTF3C1 SCAF11 MORC3 ZHX1 SENP7 SENP5 | 1.28e-04 | 591 | 97 | 11 | int:SUMO2 |
| Interaction | AMOT interactions | 1.32e-04 | 312 | 97 | 8 | int:AMOT | |
| Interaction | H3C3 interactions | CHD1 CHD7 SRCAP DNTTIP2 BPTF GTF3C1 BRPF1 SCAF11 MORC3 SENP7 | 1.36e-04 | 495 | 97 | 10 | int:H3C3 |
| Interaction | CHD4 interactions | HSPD1 FLG DCAF6 TCF7L2 FMR1 SRPK1 IKZF1 BIRC6 BPTF MTF1 DDX18 SCAF11 LRRFIP1 PPP6R3 | 1.55e-04 | 938 | 97 | 14 | int:CHD4 |
| Interaction | UNK interactions | 1.55e-04 | 408 | 97 | 9 | int:UNK | |
| Interaction | KDM1A interactions | FMR1 USP9X TNRC6B WASHC3 IKZF1 CHD7 BIRC6 DST GTF3C1 TNRC6A SMN1 LRBA EIF2AK1 PPP6R3 | 1.60e-04 | 941 | 97 | 14 | int:KDM1A |
| Interaction | CSNK2A2 interactions | HSPD1 CDK16 TCF7L2 FMR1 GRAMD1A ZFC3H1 MDM2 CREBBP GTF3C1 BRDT BRPF1 ATF1 | 1.70e-04 | 718 | 97 | 12 | int:CSNK2A2 |
| Interaction | EFTUD2 interactions | HSPD1 USP9X KIF21A ECD SRPK1 IKZF1 CHD1 MDM2 BIRC6 DNTTIP2 MTF1 DDX18 SYNE2 ATXN3 SDF2L1 SCAF11 LRRFIP1 PPP6R3 | 1.70e-04 | 1449 | 97 | 18 | int:EFTUD2 |
| Interaction | ANKHD1-EIF4EBP3 interactions | 1.75e-04 | 108 | 97 | 5 | int:ANKHD1-EIF4EBP3 | |
| Interaction | WWTR1 interactions | 2.00e-04 | 422 | 97 | 9 | int:WWTR1 | |
| Interaction | CEP152 interactions | 2.29e-04 | 179 | 97 | 6 | int:CEP152 | |
| Interaction | ELF4 interactions | 2.35e-04 | 115 | 97 | 5 | int:ELF4 | |
| Interaction | ZNFX1 interactions | 2.57e-04 | 64 | 97 | 4 | int:ZNFX1 | |
| Interaction | AGO1 interactions | 2.58e-04 | 183 | 97 | 6 | int:AGO1 | |
| Interaction | KIZ interactions | 2.91e-04 | 27 | 97 | 3 | int:KIZ | |
| Interaction | ZNF330 interactions | 3.00e-04 | 446 | 97 | 9 | int:ZNF330 | |
| Interaction | HBP1 interactions | 3.21e-04 | 123 | 97 | 5 | int:HBP1 | |
| Interaction | PJA1 interactions | 3.21e-04 | 123 | 97 | 5 | int:PJA1 | |
| Interaction | CNTRL interactions | 3.42e-04 | 193 | 97 | 6 | int:CNTRL | |
| Interaction | NLK interactions | 3.63e-04 | 70 | 97 | 4 | int:NLK | |
| Interaction | NCOR1 interactions | 3.68e-04 | 363 | 97 | 8 | int:NCOR1 | |
| Interaction | HNF4A interactions | 3.68e-04 | 275 | 97 | 7 | int:HNF4A | |
| Interaction | H3C1 interactions | LAMA2 SRPK1 CHD1 CHD7 SRCAP CREBBP DNTTIP2 BPTF GTF3C1 BRPF1 DDX18 MORC3 RSBN1L | 3.77e-04 | 901 | 97 | 13 | int:H3C1 |
| Interaction | PAX6 interactions | 3.89e-04 | 366 | 97 | 8 | int:PAX6 | |
| Interaction | MEN1 interactions | CCPG1 TCF7L2 SRPK1 CHD1 ZFC3H1 SRCAP DNTTIP2 BPTF GTF3C1 BRPF1 DDX18 SMN1 SCAF11 RSBN1L | 4.00e-04 | 1029 | 97 | 14 | int:MEN1 |
| Interaction | DDX5 interactions | FMR1 SRPK1 IKZF1 MDM2 CREBBP MTF1 DDX18 CDK5RAP2 SMN1 RBFOX2 | 4.08e-04 | 568 | 97 | 10 | int:DDX5 |
| Interaction | TNRC6A interactions | 4.10e-04 | 280 | 97 | 7 | int:TNRC6A | |
| Interaction | FEV interactions | 4.48e-04 | 203 | 97 | 6 | int:FEV | |
| Interaction | LATS2 interactions | 4.96e-04 | 289 | 97 | 7 | int:LATS2 | |
| Interaction | DDX23 interactions | 5.12e-04 | 480 | 97 | 9 | int:DDX23 | |
| Interaction | NANOG interactions | 5.20e-04 | 481 | 97 | 9 | int:NANOG | |
| Interaction | SUPV3L1 interactions | 5.63e-04 | 139 | 97 | 5 | int:SUPV3L1 | |
| Interaction | RBM38 interactions | 5.80e-04 | 34 | 97 | 3 | int:RBM38 | |
| Interaction | CEP128 interactions | 5.83e-04 | 297 | 97 | 7 | int:CEP128 | |
| Interaction | NPM1 interactions | FMR1 SRPK1 IKZF1 CHD1 MDM2 DNTTIP2 GZF1 GTF3C1 MTF1 DDX18 SYNE2 ATXN3 SMN1 RSBN1L SENP5 | 6.00e-04 | 1201 | 97 | 15 | int:NPM1 |
| Interaction | TBKBP1 interactions | 6.03e-04 | 80 | 97 | 4 | int:TBKBP1 | |
| Interaction | SRSF4 interactions | 6.19e-04 | 300 | 97 | 7 | int:SRSF4 | |
| Interaction | LAMB1 interactions | 6.20e-04 | 142 | 97 | 5 | int:LAMB1 | |
| Interaction | RPL28 interactions | 6.29e-04 | 494 | 97 | 9 | int:RPL28 | |
| Interaction | KCNN2 interactions | 6.30e-04 | 8 | 97 | 2 | int:KCNN2 | |
| Interaction | FOXO4 interactions | 6.33e-04 | 35 | 97 | 3 | int:FOXO4 | |
| Cytoband | 14q21 | 1.97e-04 | 10 | 97 | 2 | 14q21 | |
| GeneFamily | SIBLING family | 1.38e-04 | 5 | 68 | 2 | 1279 | |
| GeneFamily | SUMO specific peptidases | 2.89e-04 | 7 | 68 | 2 | 984 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.93e-04 | 9 | 68 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing | 3.05e-03 | 262 | 68 | 5 | 362 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.65e-03 | 24 | 68 | 2 | 654 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.95e-03 | 25 | 68 | 2 | 775 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FLG CHD9 CHD1 ZFC3H1 MED13L CREBBP MAP3K5 BPTF DST SCAF11 MORC3 EDRF1 | 1.08e-09 | 300 | 96 | 12 | M8702 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 5.48e-07 | 192 | 96 | 8 | M8272 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 7.18e-07 | 199 | 96 | 8 | M6987 | |
| Coexpression | CHUNG_BLISTER_CYTOTOXICITY_DN | 1.10e-06 | 50 | 96 | 5 | M10850 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CALD1 ECD TNRC6B CHD9 CHD1 CREBBP TNRC6A SDF2L1 CDK5RAP2 ZHX1 RBFOX2 | 1.15e-06 | 467 | 96 | 11 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | CALD1 ECD TNRC6B CHD9 CHD1 CREBBP TNRC6A SDF2L1 CDK5RAP2 ZHX1 RBFOX2 | 1.63e-06 | 484 | 96 | 11 | MM999 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FMR1 USP9X GRAMD1A TNRC6B DGKE IKZF1 CHD1 ZFC3H1 PTGER4 BIRC6 CREBBP DNTTIP2 ITPR1 BPTF NBEAL2 SCAF11 LRBA LRRFIP1 SENP7 | 1.68e-06 | 1492 | 96 | 19 | M40023 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | AFF2 RBMS2 ECD ANKRD26 IKZF1 MDM2 DNTTIP2 BPTF MTF1 NBEAL2 DDX18 IGKC ATXN3 SMN1 SCAF11 MPHOSPH9 LRRFIP1 SENP5 | 2.72e-06 | 1394 | 96 | 18 | M9585 |
| Coexpression | GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP | 3.65e-06 | 174 | 96 | 7 | M8925 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 6.74e-06 | 191 | 96 | 7 | M40019 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 7.98e-06 | 196 | 96 | 7 | M4244 | |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | 8.53e-06 | 198 | 96 | 7 | M8131 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 9.10e-06 | 200 | 96 | 7 | M6447 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 9.10e-06 | 200 | 96 | 7 | M9763 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TCF7L2 USP9X CHD9 CHD1 MED13L CREBBP ITPR1 BPTF DST SYNE2 MPHOSPH9 RBFOX2 LRRFIP1 | 1.45e-05 | 856 | 96 | 13 | M4500 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 1.59e-05 | 398 | 96 | 9 | M7514 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.63e-05 | 86 | 96 | 5 | M39247 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.74e-05 | 221 | 96 | 7 | M39222 | |
| Coexpression | DE_YY1_TARGETS_DN | 2.39e-05 | 93 | 96 | 5 | M3278 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 2.47e-05 | 421 | 96 | 9 | MM985 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CALD1 USP9X ZNF407 CHD1 ITPR1 BPTF SYNE2 ATXN3 CDK5RAP2 SCAF11 ZHX1 | 2.85e-05 | 656 | 96 | 11 | M18979 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 3.65e-05 | 168 | 96 | 6 | M6874 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.36e-05 | 180 | 96 | 6 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.43e-05 | 466 | 96 | 9 | M13522 | |
| Coexpression | AIZARANI_LIVER_C31_KUPFFER_CELLS_5 | 8.11e-05 | 120 | 96 | 5 | M39130 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | AFF2 CEBPG CALD1 NAA11 LAMA2 MAP3K5 TNRC6A SCAF11 ATF1 RBFOX2 | 8.11e-05 | 610 | 96 | 10 | M3854 |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 8.12e-05 | 194 | 96 | 6 | M6493 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 8.35e-05 | 195 | 96 | 6 | M8006 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP | 8.35e-05 | 195 | 96 | 6 | M8708 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 8.83e-05 | 197 | 96 | 6 | M8271 | |
| Coexpression | GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP | 8.83e-05 | 197 | 96 | 6 | M6191 | |
| Coexpression | GSE14308_TH2_VS_INDUCED_TREG_UP | 9.08e-05 | 198 | 96 | 6 | M3366 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 9.34e-05 | 199 | 96 | 6 | M3217 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | 9.34e-05 | 199 | 96 | 6 | M5729 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP | 9.34e-05 | 199 | 96 | 6 | M8744 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN | 9.60e-05 | 200 | 96 | 6 | M5073 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 9.60e-05 | 200 | 96 | 6 | M291 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | 9.60e-05 | 200 | 96 | 6 | M8040 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.19e-04 | 208 | 96 | 6 | M39233 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.96e-04 | 680 | 96 | 10 | M41089 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HSPD1 TCF7L2 CEBPG MED13L CREBBP DST MTF1 ATXN3 MORC3 TCF7L1 SENP5 | 2.11e-04 | 822 | 96 | 11 | M6782 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 2.20e-04 | 441 | 96 | 8 | M172 | |
| Coexpression | PDGF_ERK_DN.V1_DN | 2.24e-04 | 149 | 96 | 5 | M2828 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_DN | 2.69e-04 | 155 | 96 | 5 | M1304 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | JCAD CCPG1 USP9X PELI2 PTGER4 CREBBP DST LRBA ZHX1 USP33 LRRFIP1 | 2.92e-04 | 854 | 96 | 11 | M1533 |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_DN | 3.11e-04 | 160 | 96 | 5 | MM1126 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | JCAD CCPG1 USP9X PELI2 PTGER4 CREBBP DST LRBA ZHX1 USP33 LRRFIP1 | 4.06e-04 | 888 | 96 | 11 | MM1018 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 4.30e-04 | 615 | 96 | 9 | M8673 | |
| Coexpression | ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1 | 4.34e-04 | 96 | 96 | 4 | M39216 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 4.55e-04 | 267 | 96 | 6 | M41130 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 4.73e-04 | 269 | 96 | 6 | M41203 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | HSPD1 FMR1 USP9X STK26 WASHC3 CHD9 PTGER4 DNTTIP2 MAP3K5 SYNE2 ATF1 LRBA EDRF1 | 4.83e-04 | 1215 | 96 | 13 | M41122 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 4.94e-04 | 177 | 96 | 5 | M39245 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 5.33e-04 | 180 | 96 | 5 | M8127 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 5.42e-04 | 276 | 96 | 6 | M3063 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 5.42e-04 | 276 | 96 | 6 | M41128 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 5.46e-04 | 102 | 96 | 4 | M2124 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | 5.48e-04 | 506 | 96 | 8 | M253 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 6.40e-04 | 650 | 96 | 9 | MM1042 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HSPD1 CEBPG USP9X KIF21A CHD9 DGKE CHD7 MDM2 DST GTF3C1 SYNE2 | 6.87e-04 | 946 | 96 | 11 | M39169 |
| Coexpression | GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP | 7.31e-04 | 193 | 96 | 5 | M4177 | |
| Coexpression | HOFMANN_CELL_LYMPHOMA_UP | 7.31e-04 | 48 | 96 | 3 | M10783 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | TNRC6B CHD9 MED13L PTGER4 MAP3K5 ITPR1 SYNE2 ATXN3 ERCC6L2 LRRFIP1 | 7.51e-04 | 807 | 96 | 10 | M16651 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 7.65e-04 | 195 | 96 | 5 | M7310 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 7.65e-04 | 195 | 96 | 5 | M7397 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 7.65e-04 | 195 | 96 | 5 | M3089 | |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 8.01e-04 | 197 | 96 | 5 | M7696 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_DN | 8.01e-04 | 197 | 96 | 5 | M5433 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP | 8.01e-04 | 197 | 96 | 5 | M4485 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 8.19e-04 | 198 | 96 | 5 | M5293 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 8.19e-04 | 198 | 96 | 5 | M7944 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 8.19e-04 | 198 | 96 | 5 | M4462 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP | 8.37e-04 | 300 | 96 | 6 | M14151 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 8.38e-04 | 199 | 96 | 5 | M4571 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 8.38e-04 | 199 | 96 | 5 | M5159 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_MAC_DN | 8.38e-04 | 199 | 96 | 5 | M5246 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN | 8.38e-04 | 199 | 96 | 5 | M3797 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP | 8.38e-04 | 199 | 96 | 5 | M3627 | |
| Coexpression | GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN | 8.38e-04 | 199 | 96 | 5 | M4147 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 8.38e-04 | 199 | 96 | 5 | M7498 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 8.38e-04 | 199 | 96 | 5 | M3186 | |
| Coexpression | GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.38e-04 | 199 | 96 | 5 | M9159 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 8.38e-04 | 199 | 96 | 5 | M5607 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 8.57e-04 | 200 | 96 | 5 | M5030 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_DN | 8.57e-04 | 200 | 96 | 5 | M6385 | |
| Coexpression | GSE14026_TH1_VS_TH17_UP | 8.57e-04 | 200 | 96 | 5 | M3356 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP | 8.57e-04 | 200 | 96 | 5 | M8099 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 8.57e-04 | 200 | 96 | 5 | M302 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 8.57e-04 | 200 | 96 | 5 | M5282 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP | 8.57e-04 | 200 | 96 | 5 | M7018 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP | 8.57e-04 | 200 | 96 | 5 | M4031 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 8.57e-04 | 200 | 96 | 5 | M4894 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 8.57e-04 | 200 | 96 | 5 | M4884 | |
| Coexpression | GSE27786_LSK_VS_CD4_TCELL_DN | 8.57e-04 | 200 | 96 | 5 | M4747 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 8.57e-04 | 200 | 96 | 5 | M7839 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_DN | 8.57e-04 | 200 | 96 | 5 | M7293 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 8.57e-04 | 200 | 96 | 5 | M3768 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 8.57e-04 | 200 | 96 | 5 | M8497 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 8.57e-04 | 200 | 96 | 5 | M8482 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 8.57e-04 | 200 | 96 | 5 | M8500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | KIF21A ZNF407 CHD9 CHD7 SRCAP MDM2 BPTF GTF3C1 SYNE2 TNRC6A CDK5RAP2 EDRF1 WNK3 | 3.11e-06 | 595 | 97 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.49e-05 | 259 | 97 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.86e-05 | 192 | 97 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CCPG1 AFF2 KIF21A STK26 IBSP IKZF1 CHD7 MDM2 GPR179 MAP3K5 SYNE2 CDK5RAP2 LRBA SENP7 PPP6R3 | 4.09e-05 | 989 | 97 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TCF7L2 CALD1 STK26 LAMA2 CHD9 SRCAP BIRC6 CREBBP SYNE2 TNRC6A SCAF11 RBFOX2 SENP7 | 6.94e-05 | 799 | 97 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TCF7L2 CALD1 STK26 CHD9 SRCAP PTGER4 BIRC6 CREBBP SYNE2 TNRC6A SCAF11 RBFOX2 SENP7 | 7.11e-05 | 801 | 97 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | TDRD5 TCF7L2 CALD1 STK26 CHD9 SRCAP BIRC6 CREBBP BRDT SYNE2 TNRC6A SCAF11 SENP7 | 7.58e-05 | 806 | 97 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 8.45e-05 | 492 | 97 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | KIF21A STK26 ANKRD26 LAMA2 CHD7 MDM2 SYNE2 SCAF11 MPHOSPH9 SENP7 | 8.45e-05 | 492 | 97 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | CALD1 STK26 ANKRD26 CHD9 CHD7 SRCAP BIRC6 CREBBP SYNE2 SMN1 SCAF11 RBFOX2 SENP7 | 8.47e-05 | 815 | 97 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TDRD5 DCAF6 FMR1 USP9X ANKRD26 WASHC3 MAP3K5 BRDT ERCC6L2 MORC3 LRBA EDRF1 WNK3 | 9.01e-05 | 820 | 97 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.15e-04 | 413 | 97 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.17e-04 | 323 | 97 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.44e-04 | 173 | 97 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.68e-04 | 178 | 97 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 2.09e-04 | 118 | 97 | 5 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DCAF6 FMR1 NAA11 STK26 ANKRD26 CHD9 SRCAP BIRC6 BRDT SYNE2 MORC3 SENP7 | 2.16e-04 | 776 | 97 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TCF7L2 USP9X KIF21A ANKRD26 TNRC6B CHD7 MDM2 NDRG3 SYNE2 ERCC6L2 SCAF11 MPHOSPH9 | 2.26e-04 | 780 | 97 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | TDRD5 DCAF6 NAA11 CHD9 IKZF1 SRCAP BIRC6 CREBBP BRDT SYNE2 SCAF11 SENP7 | 2.69e-04 | 795 | 97 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.82e-04 | 277 | 97 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.97e-04 | 469 | 97 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | CALD1 STK26 ANKRD26 CHD9 SRCAP BIRC6 CREBBP SYNE2 SMN1 SCAF11 MORC3 SENP7 | 2.98e-04 | 804 | 97 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HSPD1 AFF2 USP9X KIF21A ANKRD26 CHD9 CHD1 CHD7 FANCM DNTTIP2 BPTF SYNE2 SCAF11 ATF1 PNPLA7 TCF7L1 WNK3 | 3.05e-04 | 1459 | 97 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.07e-04 | 281 | 97 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.40e-04 | 203 | 97 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.49e-04 | 204 | 97 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.02e-04 | 136 | 97 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.37e-04 | 298 | 97 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 4.40e-04 | 495 | 97 | 9 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | 4.42e-04 | 393 | 97 | 8 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TCF7L2 AFF2 PPFIA2 KIF21A ANKRD26 CHD9 SRPK1 CHD1 CHD7 ZFC3H1 FANCM BPTF SYNE2 TCF7L1 WNK3 SENP7 | 4.57e-04 | 1370 | 97 | 16 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 4.99e-04 | 34 | 97 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.34e-04 | 221 | 97 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | TCF7L2 AFF2 KIF21A STK26 ANKRD26 LAMA2 CHD7 MDM2 SYNE2 SCAF11 MPHOSPH9 LRBA SENP7 | 5.35e-04 | 985 | 97 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HSPD1 USP9X KIF21A ANKRD26 CHD9 CHD1 FANCM DNTTIP2 BPTF SYNE2 SCAF11 ATF1 PNPLA7 TCF7L1 WNK3 | 5.61e-04 | 1257 | 97 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.63e-04 | 311 | 97 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.87e-04 | 225 | 97 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CCPG1 KIF21A ZNF407 CHD9 CHD7 MDM2 BPTF GTF3C1 SYNE2 CDK5RAP2 | 6.02e-04 | 629 | 97 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.24e-04 | 85 | 97 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF21A ANKRD26 CHD1 CHD7 FANCM BIRC6 DNTTIP2 SCAF11 MPHOSPH9 | 7.36e-04 | 532 | 97 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DCAF6 CALD1 STK26 CHD9 SRCAP BIRC6 CREBBP SYNE2 TNRC6A SCAF11 RBFOX2 | 9.54e-04 | 790 | 97 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TDRD5 CDK16 DCAF6 AFF2 USP9X CHD7 MED13L ITPR1 DST MORC3 WNK3 | 9.64e-04 | 791 | 97 | 11 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.94e-04 | 249 | 97 | 6 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | USP9X STK26 CHD1 CHD7 BIRC6 BPTF DST ERCC6L2 ZHX1 EDRF1 RBFOX2 | 1.00e-03 | 795 | 97 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | CALD1 STK26 LAMA2 CHD9 SRCAP BIRC6 CREBBP SYNE2 TNRC6A SCAF11 SENP7 | 1.03e-03 | 797 | 97 | 11 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.11e-03 | 564 | 97 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 1.15e-03 | 100 | 97 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HSPD1 USP9X TNRC6B ZNF407 CHD1 MED13L BIRC6 ITPR1 SYNE2 LRBA | 1.17e-11 | 188 | 97 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.21e-10 | 193 | 97 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-08 | 199 | 97 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-07 | 185 | 97 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.15e-07 | 192 | 97 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.64e-07 | 198 | 97 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.83e-07 | 200 | 97 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.83e-07 | 200 | 97 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 184 | 97 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-06 | 188 | 97 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-06 | 191 | 97 | 6 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 195 | 97 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.91e-06 | 199 | 97 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.63e-05 | 171 | 97 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 175 | 97 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-05 | 175 | 97 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 187 | 97 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-05 | 187 | 97 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.70e-05 | 188 | 97 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-05 | 190 | 97 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 192 | 97 | 5 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 192 | 97 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.46e-05 | 193 | 97 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.46e-05 | 193 | 97 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 6.46e-05 | 193 | 97 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-05 | 195 | 97 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-05 | 195 | 97 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.78e-05 | 195 | 97 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 6.78e-05 | 195 | 97 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.94e-05 | 196 | 97 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 196 | 97 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-05 | 196 | 97 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 196 | 97 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.11e-05 | 197 | 97 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.46e-05 | 199 | 97 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.08e-06 | 183 | 96 | 8 | 7498_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 1.62e-06 | 193 | 96 | 8 | 1896_UP | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.88e-06 | 197 | 96 | 8 | 7440_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 1.96e-06 | 198 | 96 | 8 | 1761_DN | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.03e-06 | 199 | 96 | 8 | 5542_UP | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.84e-05 | 194 | 96 | 7 | 3021_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 2991_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 2856_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 1677_UP | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 2995_DN | |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 6599_DN | |
| Drug | SC 19220; Up 200; 10uM; PC3; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 7095_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.17e-05 | 199 | 96 | 7 | 3011_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.17e-05 | 199 | 96 | 7 | 3346_DN | |
| Drug | acridine orange | 3.91e-05 | 16 | 96 | 3 | CID000062344 | |
| Drug | TiNi | 6.58e-05 | 100 | 96 | 5 | CID000159408 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 9.59e-05 | 174 | 96 | 6 | 7530_DN | |
| Drug | torcetrapib | 1.00e-04 | 342 | 96 | 8 | ctd:C483909 | |
| Drug | B-Su | 1.05e-04 | 4 | 96 | 2 | CID000087562 | |
| Drug | PS-8 | 1.05e-04 | 4 | 96 | 2 | CID006439630 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 182 | 96 | 6 | 3887_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.26e-04 | 183 | 96 | 6 | 6937_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 184 | 96 | 6 | 2321_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.30e-04 | 184 | 96 | 6 | 4755_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.30e-04 | 184 | 96 | 6 | 4610_DN | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 1.47e-04 | 188 | 96 | 6 | 7050_DN | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 6621_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 1.74e-04 | 194 | 96 | 6 | 1715_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 4662_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 4105_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 2668_UP | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 7425_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 3327_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A | 1.84e-04 | 196 | 96 | 6 | 1440_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 4760_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 2980_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 5884_DN | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 6514_UP | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 3019_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 3006_DN | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; HL60; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 2565_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 4837_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3003_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3016_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 5849_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1377_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1579_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1812_DN | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1800_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3472_DN | |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 6307_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 5520_UP | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 7266_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 5304_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3013_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2094_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; HL60; HG-U133A | 2.00e-04 | 199 | 96 | 6 | 1776_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HG-U133A | 2.00e-04 | 199 | 96 | 6 | 1893_UP | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; HL60; HG-U133A | 2.00e-04 | 199 | 96 | 6 | 1737_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HG-U133A | 2.00e-04 | 199 | 96 | 6 | 1892_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 3032_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 7461_DN | |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 6470_UP | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.14e-05 | 152 | 97 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.43e-05 | 93 | 97 | 5 | C1535926 | |
| Disease | Fragile X Syndrome | 3.20e-05 | 3 | 97 | 2 | C0016667 | |
| Disease | FRAXE Syndrome | 3.20e-05 | 3 | 97 | 2 | C0751157 | |
| Disease | FRAXA Syndrome | 3.20e-05 | 3 | 97 | 2 | C0751156 | |
| Disease | obesity (implicated_via_orthology) | 7.94e-05 | 215 | 97 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy (disorder) | 1.59e-04 | 6 | 97 | 2 | C0699743 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.22e-04 | 7 | 97 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | total blood protein measurement | 7.14e-04 | 449 | 97 | 7 | EFO_0004536 | |
| Disease | Malignant neoplasm of breast | IBSP LAMA2 DGKE MDM2 RNF115 DDX18 SYNE2 MAP3K13 LRBA TCF7L1 LRRFIP1 | 8.06e-04 | 1074 | 97 | 11 | C0006142 |
| Disease | Common variable immunodeficiency | 8.15e-04 | 13 | 97 | 2 | cv:C0009447 | |
| Disease | Prostatic Neoplasms | 9.78e-04 | 616 | 97 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.78e-04 | 616 | 97 | 8 | C0376358 | |
| Disease | bitter alcoholic beverage consumption measurement | 9.89e-04 | 133 | 97 | 4 | EFO_0010092 | |
| Disease | grip strength measurement | 1.07e-03 | 350 | 97 | 6 | EFO_0006941 | |
| Disease | age at onset, Myopia | 1.54e-03 | 150 | 97 | 4 | EFO_0004847, HP_0000545 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.54e-03 | 69 | 97 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.82e-03 | 157 | 97 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | neutrophil count | JCAD CHD9 IKZF1 CHD7 CREBBP MAP3K5 GTF3C1 NBEAL2 TNRC6A LRBA TCF7L1 HYDIN | 1.91e-03 | 1382 | 97 | 12 | EFO_0004833 |
| Disease | granulocyte percentage of myeloid white cells | 1.94e-03 | 268 | 97 | 5 | EFO_0007997 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 1.96e-03 | 20 | 97 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | chronic obstructive pulmonary disease | 1.96e-03 | 688 | 97 | 8 | EFO_0000341 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 2.59e-03 | 23 | 97 | 2 | MONDO_0015335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLTQSEQSADGSQSE | 851 | Q8NAT2 | |
| SDSGASNETTNALQE | 501 | Q9Y2D5 | |
| RTQGESISEQGSTDN | 596 | Q9NR09 | |
| SISEQGSTDNESCTN | 601 | Q9NR09 | |
| TAGDSDDSLQQSSVQ | 2441 | Q9NR09 | |
| TDITETTGRENTNEA | 391 | Q58F21 | |
| TTGRENTNEASSEGN | 396 | Q58F21 | |
| TEESASETTQTEING | 801 | Q8IZF6 | |
| STSDSNTDQEETLQI | 716 | P51816 | |
| QNFSESQEVEVSSGS | 141 | Q9H116 | |
| EEEESSSNGTASQST | 1061 | Q92793 | |
| VANNTNEEAGDGTTT | 101 | P10809 | |
| SDQTSTESATNENNT | 611 | Q58WW2 | |
| TNSEGHSEDSDTQSV | 1396 | P20930 | |
| SQNSNSVDESSEDSL | 231 | Q9UPS8 | |
| NLGDNTTNATSEETS | 636 | Q12830 | |
| DSPSNTSQSEQQESV | 781 | Q9P2D1 | |
| DEESVRNSSGESSQS | 6 | O14646 | |
| VSQTTDNNSDEEDSG | 571 | O95905 | |
| EEQVDSQPDASSSQT | 296 | Q96CP6 | |
| GTDQSESINTSNETE | 1096 | Q96SN8 | |
| SSVSVEESSGQQNQV | 376 | Q15434 | |
| TDGQQSQTQSSENSE | 101 | O43251 | |
| ESFSSNQSTESTQDE | 76 | O60268 | |
| SVTSNQSDGTQESCE | 346 | Q9UGV2 | |
| SSSQPSQDGQESVTE | 1641 | Q71F56 | |
| QEAESQSSSLTEDSG | 2331 | Q6PRD1 | |
| FDESNSQTSETSSGN | 1011 | Q14643 | |
| AEQQESSSSDQTNDS | 226 | Q3B7T1 | |
| EDSQESQVFSGSDIT | 1021 | Q03001 | |
| SSSSEESEAEPQQEN | 856 | Q9P266 | |
| QDMTQTSGTNLTSEE | 266 | P54252 | |
| INQGSSSSVIESDEE | 821 | Q8IYD8 | |
| QQTATDVSTSSNIEE | 866 | Q14149 | |
| ISETSDSSQGQDSES | 436 | P35408 | |
| TSNDISVNTVDEENT | 391 | Q99550 | |
| QTDTETQDSKDSGIQ | 1166 | P50851 | |
| IDTNQEENIATSSSG | 2441 | P24043 | |
| SNSCQDSTDTESNNE | 391 | Q13422 | |
| LSSTSSSGQQDFENE | 96 | O94886 | |
| SNLTLSETQNGDVSE | 31 | Q9NVP1 | |
| LSSQENSSESQEEVV | 346 | Q13316 | |
| NSSESQEEVVSESRG | 351 | Q13316 | |
| STSAQQGSDLEDESS | 1281 | Q6ZV29 | |
| CDSEENTEGTSLTQQ | 371 | Q9UHF4 | |
| DESETAVSQGNSNTV | 91 | O43283 | |
| RTESQSSENGGENSV | 2756 | Q3L8U1 | |
| QPSDDESSSDETSNQ | 156 | Q9ULG6 | |
| GTNSEASNASETESD | 491 | Q06787 | |
| EEDITSSDQGTSNST | 1931 | Q4G0P3 | |
| NDEANQSDTSVSLSE | 196 | O95684 | |
| TSTEESSEENVNFLG | 356 | Q9BQI3 | |
| ESDQASATSSDEVQS | 81 | Q00536 | |
| NSQESVTEQDSKDST | 51 | P01834 | |
| NDASTENQNTDSESS | 61 | A6NGE4 | |
| SGEQTDDDISSTSDQ | 546 | P52429 | |
| SPSDTDENATNTQST | 1546 | Q5T890 | |
| EETSGQDSSLKDQTN | 1181 | Q99590 | |
| DNVQSISTENTTADG | 131 | P53567 | |
| NSEIATNGETSDTLN | 256 | Q32MZ4 | |
| LSNGSIDSTDETSQI | 256 | O75334 | |
| DSAQEEGTVQATSSQ | 296 | Q9P2P1 | |
| LNSSGTNTEDSELTD | 1301 | Q99683 | |
| EEDTSQNTATHETGT | 696 | Q6PCB5 | |
| LIQQSEQSESETAGS | 1846 | Q93008 | |
| TEGSLSDTDNLQSEQ | 186 | Q9BQF6 | |
| SLNGEDSTRQSQSTE | 271 | Q9Y4L5 | |
| QATSDVQESTQESAA | 2381 | Q8WXH0 | |
| SEGSDSESTSRENNT | 306 | Q9P289 | |
| TDSELRENSSTTQGQ | 346 | Q14872 | |
| VTDTISGSQNTDEAQ | 116 | Q9HAT8 | |
| SGSQNTDEAQITQST | 121 | Q9HAT8 | |
| DDTSNTSNPQQTSEE | 1426 | Q6ZNJ1 | |
| NQQESSDSGTSVSEN | 111 | Q00987 | |
| SLGTEEESSKQQESQ | 1066 | Q14524 | |
| ENEQGINGTSTNSTE | 171 | P21815 | |
| NESQVSTDESENSRS | 161 | Q16637 | |
| QNGDSSTSQETDSCT | 401 | Q96SB4 | |
| SESEESEDAQSQSQA | 526 | Q6ZRS2 | |
| GQTDSAAEESSSQET | 856 | P55201 | |
| TTTTNTQVEGDDEAA | 81 | Q05682 | |
| QVSSLSESEESQDSS | 31 | P18846 | |
| SSDESQQSENSENEE | 446 | Q5QJE6 | |
| TLGQENQTSSVSDDR | 396 | Q96HI0 | |
| ENQETQGSTLSDSEE | 176 | Q9BSU3 | |
| ESVESTNVQDSSESS | 211 | Q9BSU3 | |
| QQSVTGVEASDDANS | 66 | Q9HCN8 | |
| SEQTEEQGSSRNTFQ | 281 | Q5PRF9 | |
| NESENQSSSSDSEAE | 71 | Q9HCS4 | |
| NTSVQQDKSDESDSS | 1296 | Q7Z4S6 | |
| NSETQSGQDSVGTDS | 171 | O60784 | |
| SGQDSVGTDSSQQED | 176 | O60784 | |
| ESETNQNSSSDSEAE | 51 | Q9NQB0 | |
| ENAEQAESTEVSSSG | 161 | Q9UKY1 | |
| TEATQGQRQSSSEIE | 736 | Q8NEE8 | |
| VTTSETQEAEQGQGS | 491 | Q9C0G0 | |
| NSSTDQGSDEEGSLQ | 1061 | Q12789 | |
| STQDSGLQESEVSAE | 111 | Q9Y3C0 | |
| NTENATITDQDSTGD | 406 | Q5H9R7 | |
| EDEEENSSSSSQLNS | 201 | P50607 | |
| SDTTDSSQGLQDKEQ | 331 | O60293 | |
| EEDQGSATSQTNEQS | 646 | Q8NDV7 | |
| DQSVTEVSESTVQNA | 691 | Q8TEY7 | |
| KDTESSSENTTDNNS | 206 | Q9UPQ9 | |
| DSNSSQTGSSEQVQI | 836 | Q9BYP7 |